Vascular targeting to the SST2 receptor improves the therapeutic response to near-IR two-photon activated PDT for deep-tissue cancer treatment

Biochimica et Biophysica Acta - General Subjects

Volumn 1830, Issue 10, 2013, Pages 4594-4603

  Starkey, Jean R ^a   Pascucci, Elizabeth M ^a   Drobizhev, Mikhail A ^a   Elliott, Aleisha ^a   Rebane, Aleksander K ^a,b  

^a MONTANA STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF CHEMICAL PHYSICS AND BIOPHYSICS   (Estonia)

Author keywords

Laser pulse; Photodynamic therapy; Somatostatin receptor 2; Vascular shutdown

Indexed keywords

ANTINEOPLASTIC AGENT; BUPRENORPHINE; DEXTRAN; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORESCEIN ISOTHIOCYANATE; OCTREOTATE; POLYPEPTIDE; PORPHYRIN; SOMATOSTATIN RECEPTOR 2; TYROSYLHISTIDINYLTRYPTOPHYLTYROSYLGLYCYLTYROSYLTHREONYLPROPYLGLUTAMINYLASPARAGINYLVALYLISOLEUCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER REGRESSION; CANCER THERAPY; CONTROLLED STUDY; DEEP TISSUE CANCER TREATMENT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; MOUSE; NEAR INFRARED TWO PHOTON ACTIVATED PHOTODYNAMIC THERAPY; NONHUMAN; PHOTOACTIVATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION;

1-ETHYL-3-[3-DIMETHYLAMINOPROPYL]CARBODIIMIDE HYDROCHLORIDE; AMERICAN TYPE CULTURE COLLECTION; ATCC; BAE; BOVINE AORTIC ENDOTHELIAL; CALCIUM AND MAGNESIUM FREE SALINE; CMF; DMEM; DULBECCO'S MINIMAL ESSENTIAL MEDIUM; EDC; EDTA; EGF; EPIDERMAL GROWTH FACTOR; ETHYLENEDIAMINETETRAACETIC ACID; FITC; FLUORESCEIN ISOTHIOCYANATE; GE11 PEPTIDE; LASER PULSE; NEAR INFRARED; NIR; PBS; PDT; PHOSPHATE BUFFERED SALINE; PHOTODYNAMIC THERAPY; SCID; SEVERE COMBINED IMMUNODEFICIENT; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN TYPE 2 RECEPTOR; SST2R; UCNP; UPCONVERSION NANOPARTICLE; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR SHUTDOWN; VEGF; YHWYGYTPQNVI;

BLOOD VESSELS; CELL LINE, TUMOR; HUMANS; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTONS; RECEPTORS, SOMATOSTATIN; SPECTROSCOPY, NEAR-INFRARED;

BOVINAE; MURINAE;

EID: 84879492608     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.05.043     Document Type: Article

References (58)

1. M. Triesscheijn, P. Baas, J.H. Schellens, and F.A. Stewart Photodynamic therapy in oncology Oncologist 11 2006 1034 1044 (Pubitemid 44564813)
2. W.M. Sharman, C.M. Allen, and J.E. van Lier Role of activated oxygen species in photodynamic therapy Methods Enzymol. 319 2000 376 400 (Pubitemid 30448059)
3. B. Stott, and M. Korbelik Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy Cancer Immunol. Immunother. 56 2007 649 658 (Pubitemid 46348734)
4. A.P. Castano, P. Mroz, and M.R. Hamblin Photodynamic therapy and anti-tumour immunity Nat. Rev. Cancer 6 2006 535 545 (Pubitemid 43980542)
5. C.M. Brackett, and S.O. Gollnick Photodynamic therapy enhancement of anti-tumor immunity Photochem. Photobiol. Sci. 10 2011 649 652
6. A. Weiss, H. den Bergh, A.W. Griffioen, and P. Nowak-Sliwinska Angiogenesis inhibition for the improvement of photodynamic therapy: the revival of a promising idea Biochim. Biophys. Acta 1826 2012 53 70
7. J.R. Starkey, A.K. Rebane, M.A. Drobizhev, F. Meng, A. Gong, A. Elliott, K. McInnerney, and C.W. Spangler New two-photon activated photodynamic therapy sensitizers induce xenograft tumor regressions after near-IR laser treatment through the body of the host mouse Clin. Cancer Res. 14 2008 6564 6573
8. A. Karotki, K. Kruk, M. Drobizhev, A. Rebane, E. Nickel, and C.W. Spangler Efficient singlet oxygen generation upon two-photon excitation of new porphyrin with enhanced nonlinear absorption IEEE J. Sel. Top. Quantum Electron. 7 2001 971 973
9. A. Casas, G. Di Venosa, T. Hasan, and B. Al Mechanisms of resistance to photodynamic therapy Curr. Med. Chem. 18 2011 2486 2515
10. C. Wang, H. Tao, L. Cheng, and Z. Liu Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles Biomaterials 32 2011 6145 6154
11. X. Huang, I.H. El-Sayed, W. Qian, and M.A. El-Sayed Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods J. Am. Chem. Soc. 128 2006 2115 2120 (Pubitemid 43277351)
12. E.C. Dreaden, S.C. Mwakwari, L.A. Austin, M.J. Kieffer, A.K. Oyelere, and M.A. El-Sayed Small molecule-gold nanorod conjugates selectively target and induce macrophage cytotoxicity towards breast cancer cells Small 8 2012 2819 2822
13. P. Nowak-Sliwinska, J.R. van Beijnum, M. van Berkel, H. van den Bergh, and A.W. Griffioen Vascular regrowth following photodynamic therapy in the chicken embryo chorioallantoic membrane Angiogenesis 13 2010 281 292
14. P. Nowak-Sliwinska, A. Weiss, J.R. van Beijnum, T.J. Wong, J.P. Ballini, B. Lovisa, H. van den Bergh, and A.W. Griffioen Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion J. Cell. Mol. Med. 16 2012 1553 1562
15. A. Ferrario, K.F. von Tiehl, N. Rucker, M.A. Schwarz, P.S. Gill, and C.J. Gomer Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma Cancer Res. 60 2000 4066 4069 (Pubitemid 30636586)
16. F. Jiang, X. Zhang, S.N. Kalkanis, Z. Zhang, H. Yang, M. Katakowski, X. Hong, X. Zheng, Z. Zhu, and M. Chopp Combination therapy with antiangiogenic treatment and photodynamic therapy for the nude mouse bearing U87 glioblastoma Photochem. Photobiol. 84 2008 128 137 (Pubitemid 350265084)
17. J. Cheng, J. Xu, J. Duanmu, H. Zhou, C.J. Booth, and Z. Hu Effective treatment of human lung cancer by targeting tissue factor with a factor VII-targeted photodynamic therapy Curr. Cancer Drug Targets 11 2011 1069 1081
18. C. Orlando, C.C. Raggi, S. Bianchi, V. Distante, L. Simi, V. Vezzosi, S. Gelmini, P. Pinzani, M.C. Smith, A. Buonamano, E. Lazzeri, M. Pazzagli, L. Cataliotti, M. Maggi, and M. Serio Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue Endocr. Relat. Cancer 11 2004 323 332 (Pubitemid 38832833)
19. J.C. Reubi, J.C. Schaer, R. Markwalder, B. Waser, U. Horisberger, and J. Laissue Distribution of somatostatin receptors in normal and neoplastic human tissues: recent advances and potential relevance Yale J. Biol. Med. 70 1997 471 479 (Pubitemid 28515732)
20. S. Schulz, S. Schulz, J. Schmitt, D. Wiborny, H. Schmidt, S. Olbricht, W. Weise, A. Roessner, C. Gramsch, and V. Hollt Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B, and sst3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies Clin. Cancer Res. 4 1998 2047 2052 (Pubitemid 28415646)
21. J.C. Watson, D.A. Balster, B.M. Gebhardt, T.M. O'Dorisio, M.S. O'Dorisio, G.D. Espenan, G.J. Drouant, and E.A. Woltering Growing vascular endothelial cells express somatostatin subtype 2 receptors Br. J. Cancer 85 2001 266 272 (Pubitemid 32695750)
22. R.L. Adams, I.P. Adams, S.W. Lindow, W. Zhong, and S.L. Atkin Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endothelium Br. J. Cancer 92 2005 1493 1498 (Pubitemid 40705017)
23. P. Dasgupta Somatostatin analogues: multiple roles in cellular proliferation, neoplasia, and angiogenesis Pharmacol. Ther. 102 2004 61 85 (Pubitemid 38429986)
24. N. Garcia de la Torre, J.A. Wass, and H.E. Turner Antiangiogenic effects of somatostatin analogues Clin. Endocrinol. 57 2002 425 441 (Pubitemid 35216294)
25. W. Mier, R. Eritja, A. Mohammed, U. Haberkorn, and M. Eisenhut Peptide-PNA conjugates: targeted transport of antisense therapeutics into tumors Angew. Chem. 42 2003 1968 1971 (Pubitemid 36565812)
26. Z. Li, R. Zhao, X. Wu, Y. Sun, M. Yao, J. Li, Y. Xu, and J. Gu Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics FASEB J. 19 2005 1978 1985 (Pubitemid 41759743)
27. J.E. Taylor, M.A. Theveniau, R. Bashirzadeh, T. Reisine, and P.A. Eden Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: evidence for SSTR2 heterogeneity Peptides 15 1994 1229 1236 (Pubitemid 24337076)
28. T. Nayak, J. Norenberg, T. Anderson, and R. Atcher A comparison of high- versus low-linear energy transfer somatostatin receptor targeted radionuclide therapy in vitro Cancer Biother. Radiopharm. 20 2005 52 57 (Pubitemid 40478522)
29. S.R. Rangan A new human cell line (FaDu) from a hypopharyngeal carcinoma Cancer 29 1972 117 121
30. I. Keydar, L. Chen, S. Karby, F.R. Weiss, J. Delarea, M. Radu, S. Chaitcik, and H.J. Brenner Establishment and characterization of a cell line of human breast carcinoma origin Eur. J. Cancer 15 1979 659 670 (Pubitemid 9198534)
31. J.S. Bertram, and P. Janik Establishment of a cloned line of Lewis lung carcinoma cells adapted to cell culture Cancer Lett. 11 1980 63 73 (Pubitemid 11198069)
32. R.L. Heimark, and S.M. Schwartz The role of membrane-membrane interactions in the regulation of endothelial cell growth J. Cell Biol. 100 1985 1934 1940 (Pubitemid 15042089)
33. A. Vasilaki, T. Papadaki, G. Notas, G. Kolios, N. Mastrodimou, D. Hoyer, M. Tsilimbaris, E. Kouroumalis, I. Pallikaris, and K. Thermos Effect of somatostatin on nitric oxide production in human retinal pigment epithelium cell cultures Invest. Ophthalmol. Vis. Sci. 45 2004 1499 1506 (Pubitemid 38859331)
34. B. Waser, M.L. Tamma, R. Cescato, H.R. Maecke, and J.C. Reubi Highly efficient in vivo agonist-induced internalization of sst2 receptors in somatostatin target tissues J. Nucl. Med. 50 2009 936 941
35. N.S. Callander, N. Varki, and L.V. Rao Immunohistochemical identification of tissue factor in solid tumors Cancer 70 1992 1194 1201
36. T.A. Drake, J.H. Morrissey, and T.S. Edgington Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis Am. J. Pathol. 134 1989 1087 1097 (Pubitemid 19142892)
37. S. Takano, K. Tsuboi, Y. Tomono, Y. Mitsui, and T. Nose Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression Br. J. Cancer 82 2000 1967 1973 (Pubitemid 30326458)
38. Y. Tang, P. Borgstrom, J. Maynard, J. Koziol, Z. Hu, A. Garen, and A. Deisseroth Mapping of angiogenic markers for targeting of vectors to tumor vascular endothelial cells Cancer Gene Ther. 14 2007 346 353 (Pubitemid 46425788)
39. J. Contrino, G. Hair, D.L. Kreutzer, and F.R. Rickles In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease Nat. Med. 2 1996 209 215 (Pubitemid 26054985)
40. P.S. Bora, Z. Hu, T.H. Tezel, J.H. Sohn, S.G. Kang, J.M. Cruz, N.S. Bora, A. Garen, and H.J. Kaplan Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration Proc. Natl. Acad. Sci. U.S.A. 100 2003 2679 2684 (Pubitemid 36297558)
41. Z. Hu, and A. Garen Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer Proc. Natl. Acad. Sci. U.S.A. 98 2001 12180 12185 (Pubitemid 32959847)
42. Z. Hu, B. Rao, S. Chen, and J. Duanmu Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice BMC Cancer 10 2010 235
43. Z. Hu, B. Rao, S. Chen, and J. Duanmu Selective and effective killing of angiogenic vascular endothelial cells and cancer cells by targeting tissue factor using a factor VII-targeted photodynamic therapy for breast cancer Breast Cancer Res. Treat. 126 2011 589 600
44. Z. Hu, Y. Sun, and A. Garen Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model Proc. Natl. Acad. Sci. U.S.A. 96 1999 8161 8166 (Pubitemid 29328425)
45. C. Flossel, T. Luther, M. Muller, S. Albrecht, and M. Kasper Immunohistochemical detection of tissue factor (TF) on paraffin sections of routinely fixed human tissue Histochemistry 101 1994 449 453
46. U. Sturm, T. Luther, S. Albrecht, C. Flossel, H. Grossmann, and M. Muller Immunohistological detection of tissue factor in normal and abnormal human mammary glands using monoclonal antibodies Virchows Arch. A Pathol. Anat. Histopathol. 421 1992 79 86
47. E.K. Spicer, R. Horton, L. Bloem, R. Bach, K.R. Williams, A. Guha, J. Kraus, T.C. Lin, Y. Nemerson, and W.H. Konigsberg Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA Proc. Natl. Acad. Sci. U.S.A. 84 1987 5148 5152 (Pubitemid 17119118)
48. S.K. Mandal, U.R. Pendurthi, and L.V. Rao Cellular localization and trafficking of tissue factor Blood 107 2006 4746 4753 (Pubitemid 43882625)
49. T. Sun, B.C. Sun, X.L. Zhao, N. Zhao, X.Y. Dong, N. Che, Z. Yao, Y.M. Ma, Q. Gu, W.K. Zong, and Z.Y. Liu Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: a study of hepatocellular carcinoma Hepatology 54 2011 1690 1706
50. X.H. Yao, Y.F. Ping, and X.W. Bian Contribution of cancer stem cells to tumor vasculogenic mimicry Protein Cell 2 2011 266 272
51. B.W. Henderson, S.O. Gollnick, J.W. Snyder, T.M. Busch, P.C. Kousis, R.T. Cheney, and J. Morgan Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors Cancer Res. 64 2004 2120 2126 (Pubitemid 38339462)
52. M.E. Rodriguez, P. Zhang, K. Azizuddin, G.B. Delos Santos, S.M. Chiu, L.Y. Xue, J.C. Berlin, X. Peng, H. Wu, M. Lam, A.L. Nieminen, M.E. Kenney, and N.L. Oleinick Structural factors and mechanisms underlying the improved photodynamic cell killing with silicon phthalocyanine photosensitizers directed to lysosomes versus mitochondria Photochem. Photobiol. 85 2009 1189 1200
53. E. Panzarini, V. Inguscio, and L. Dini Timing the multiple cell death pathways initiated by Rose Bengal acetate photodynamic therapy Cell Death Dis. 2 2011 e169
54. J.S. Dysart, and M.S. Patterson Characterization of photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro Phys. Med. Biol. 50 2005 2597 2616 (Pubitemid 40770642)
55. K. Klutz, D. Schaffert, M.J. Willhauck, G.K. Grunwald, R. Haase, N. Wunderlich, C. Zach, F.J. Gildehaus, R. Senekowitsch-Schmidtke, B. Goke, E. Wagner, M. Ogris, and C. Spitzweg Epidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene Mol. Ther. 19 2011 676 685
56. H. van Cruijsen, G. Giaccone, and K. Hoekman Epidermal growth factor receptor and angiogenesis: opportunities for combined anticancer strategies Int. J. Cancer 117 2005 883 888 (Pubitemid 41688561)
57. G.J. Cerniglia, N. Pore, J.H. Tsai, S. Schultz, R. Mick, R. Choe, X. Xing, T. Durduran, A.G. Yodh, S.M. Evans, C.J. Koch, S.M. Hahn, H. Quon, C.M. Sehgal, W.M. Lee, and A. Maity Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy PLoS One 4 2009 e6539
58. D.N. Amin, D.R. Bielenberg, E. Lifshits, J.V. Heymach, and M. Klagsbrun Targeting EGFR activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cells Microvasc. Res. 76 2008 15 22